Trial intelligence / Profile preview

Ketoprofen patch vs LOXONIN TAPE vs placebo for knee osteoarthritis

ChiCTR2500105433Phase 3Recruiting

Sponsor
Nanjing Drum-Tower Hospital
Start
Jul 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of ketoprofen in knee osteoarthritis (OA) (3 arms), sponsored by Nanjing Drum-Tower Hospital. Primary endpoint: Change from baseline in WOMAC pain subscale item 1 (walking on flat surfaces) VAS score at week 4 for target knee. Started Jul 2025; status: recruiting.

02

Drugs

ketoprofen
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on ChiCTR2500105433.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500105433.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call